Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
British Journal of Clinical Pharmacology|December 15, 2016
Assessment of pharmacokinetic interaction between rilotumumab and epirubicin, cisplatin and capecitabine (ECX) in a Phase 3 study in gastric cancerYilong Zhang, Mita Kuchimanchi, Min Zhu, et al.British Journal of Clinical Pharmacology|November 23, 2012
Romiplostim dose-response in patients with myelodysplastic syndromesJuan Jose Perez Ruixo, Sameer Doshi, Yow-Ming C Wang, et al.Clinical Pharmacokinetics|August 6, 2013
Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agentsSameer Doshi, Wojciech Krzyzanski, Susan Yue, et al.Clinical Pharmacokinetics|May 23, 2016
Blinatumomab, a Bispecific T-cell Engager (BiTE(®)) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its ImplicationsMin Zhu, Benjamin Wu, Christian Brandl, et al.Journal of Clinical Pharmacology|September 19, 2017
Blinatumomab Pharmacodynamics and Exposure-Response Relationships in Relapsed/Refractory Acute Lymphoblastic LeukemiaMin Zhu, Andrea Kratzer, Jessica Johnson, et al.Journal of Pharmaceutical Sciences|October 7, 2008
Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major roleBalaji Agoram, Ken Aoki, Sameer Doshi, et al.CPT: Pharmacometrics & Systems Pharmacology|September 25, 2018
Receiver Operating Characteristic Analysis and Clinical Trial Simulation to Inform Dose Titration DecisionsJohn David Clements, Juan Jose Perez Ruixo, John P Gibbs, et al.Journal of Pharmacokinetics and Pharmacodynamics|May 9, 2018
Population pharmacokinetics and exposure-response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemiaMita Kuchimanchi, Anita Grover, Maurice G Emery, et al.The AAPS Journal|October 22, 2010
Pharmacodynamics-mediated drug disposition (PDMDD) and precursor pool lifespan model for single dose of romiplostim in healthy subjectsYow-Ming C Wang, Wojciech Krzyzanski, Sameer Doshi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
Rilotumumab exposure-response relationship in patients with advanced or metastatic gastric cancerSameer Doshi, Per Olsson Gisleskog, Yilong Zhang, et al.Pageof 4